{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreifxfzunzm2q4ftqn6i2263w5aw4g6gptoo4g5ihpnimzoflpkc6qy",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mfmpz7htgyu2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreif46rqteqap7552i7ckkwvpqygopcmcvzdqefksgkjoqkfiqzec2i"
    },
    "mimeType": "image/jpeg",
    "size": 78746
  },
  "path": "/2026/02/24/ibd-combination-therapy-race-abbvie-lilly-pfizer-merck-jnj/?utm_campaign=rss",
  "publishedAt": "2026-02-24T09:30:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "biotechnology",
    "chronic diseases",
    "drug development",
    "Pharmaceuticals",
    "STAT+"
  ],
  "textContent": "New treatment approaches could give inflammatory bowel disease patients hope, and make drugmakers a bonanza.",
  "title": "STAT+: New treatment approach could give IBD patients hope, and be a bonanza for drugmakers",
  "updatedAt": "2026-02-24T12:11:42.000Z"
}